For some patients, adding aspirin to a direct oral anticoagulant rarely adds up, a new study finds.

Vascular experts are wading through a constant stream of data to continue refining the best approaches to avoid dangerous thrombosis events in people sick with the novel coronavirus.

A study reveals the virus triggers production of antibodies circulating through the blood, causing clots in people hospitalized with the disease.

Hundreds of thousands of hospital patients get a pricey genetic test. But it’s often unnecessary, a team of U-M clinicians says.

U-M researchers are probing the cause of cancer-related deep vein thrombosis in hopes of developing new therapies.